Magnus Sabel
- Genetics top 5%
- Glioma Diagnosis and Treatment 11
-
- Neuroblastoma Research and Treatments 3
- Neurofibromatosis and Schwannoma Cases 3
- Speech and Hearing top 10%
-
- Childhood Cancer Survivors' Quality of Life 3
-
- Epigenetics and DNA Methylation 3
- Chromatin Remodeling and Cancer 3
- Cancer therapeutics and mechanisms 2
-
- Neurogenesis and neuroplasticity mechanisms 3
- Co-authors
- Birgitta LanneringJan‐Inge HenterKlas BlomgrenYenan T. BrycesonMarie MeethsAnnaCarin HorneDaniel ArvidssonHelena Carén
- Cited by
- GeneticsHematologyNeurology
- Partner nations
- SwedenUnited StatesItaly
In The Last Decade
Magnus Sabel
18 papers receiving 393 citations
Peers
Comparison fields: 5 of 65
- Genetics 181
- Hematology 60
- Neurology 67
- Speech and Hearing 29
- Pediatrics, Perinatology and Child Health 79
Countries citing papers authored by Magnus Sabel
This map shows the geographic impact of Magnus Sabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Sabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Sabel more than expected).
Fields of papers citing papers by Magnus Sabel
This network shows the impact of papers produced by Magnus Sabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Sabel. The network helps show where Magnus Sabel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Magnus Sabel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 16 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 8 | |
| 7 | 2018 | 14 | |
| 8 | 2017 | 4 | |
| 9 | 2017 | 25 | |
| 10 | 2017 | 1 | |
| 11 | Brain tumors in children. Intervening with the aftermath: relapse and long term side effects | 2017 | 0 |
| 12 | 2017 | 1 | |
| 13 | 2017 | 28 | |
| 14 | 2016 | 78 | |
| 15 | 2016 | 63 | |
| 16 | 2016 | 32 | |
| 17 | 2016 | 3 | |
| 18 | 2015 | 30 | |
| 19 | 2014 | 18 | |
| 20 | 2014 | 60 |
About Magnus Sabel
Magnus Sabel is a scholar working on Genetics, Developmental Neuroscience and Neurology, having authored 20 papers that have together received 394 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Epigenetics and DNA Methylation (3 papers), Neuroblastoma Research and Treatments (3 papers), Chromatin Remodeling and Cancer (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Genetics (181 citations), Hematology (60 citations) and Neurology (67 citations). Magnus Sabel has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Birgitta Lannering, Jan‐Inge Henter, Klas Blomgren, Yenan T. Bryceson, Marie Meeths, AnnaCarin Horne, Daniel Arvidsson, Helena Carén, Ingrid Emanuelson and Jürgen Broeren. Their work appears in journals such as PLoS ONE, Carcinogenesis and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.